Current Drug Targets


Francis J. Castellino
(14643 citations)
Dean Emeritus, College of Science,
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 16 Issue: 11, October 2015

Meet Our Editorial Board Member: free to download

Volume:16   Issue: 11
Pp: 1161-1161
Mark J. Walker
DOI: 10.2174/138945011611151013162936
Published on: 13 October, 2015

Editorial (Thematic Issue: Combination Pharmacological Treatments for LUTS) free to download

Volume:16   Issue: 11
Pp: 1162-1164
Petros Sountoulides and Apostolos Apostolidis
DOI: 10.2174/138945011611151013163437
Published on: 13 October, 2015

Current Pharmacological Treatment for Male LUTS due to BPH: Dutasteride or Finasteride?

Volume:16   Issue: 11
Pp: 1165-1171
Luisella Pirozzi, Petros Sountoulides, Pietro Castellan, Fabrizio Presicce, Riccardo Lombardo, Marilena Romero, Cosimo De Nunzio, Andrea Tubaro, Luigi Schips and Luca Cindolo
DOI: 10.2174/1389450116666150518101617
Published on: 17 May, 2015

The Impact of Combination Therapy with a-Blockers and 5ARIs on the Progression of BPH

Volume:16   Issue: 11
Pp: 1172-1179
Petros Sountoulides and Stavros Gravas
DOI: 10.2174/1389450116666150223164032
Published on: 23 February, 2015

PDE-5 Inhibitors for BPH-Associated LUTS

Volume:16   Issue: 11
Pp: 1180-1186
Philip Brousil, Majid Shabbir, E. Zacharakis and Arun Sahai
DOI: 10.2174/138945011611151013164756
Published on: 13 October, 2015

Antimuscarinics in the Treatment of OAB: Is there a First-Line and a Second-Line Choice?

Volume:16   Issue: 11
Pp: 1187-1197
Apostolos Apostolidis
DOI: 10.2174/1389450116666150518102021
Published on: 17 May, 2015

The Current Indications and the Benefits of Combining a β3-Agonist with an Anticholinergic for the Treatment of OAB

Volume:16   Issue: 11
Pp: 1198-1206
Cosimo De Nunzio, Fabrizio Presicce, Luisella Pirozzi, Pietro Castellan, Luigi Schips, Luca Cindolo, Riccardo Lombardo and Andrea Tubaro
DOI: 10.2174/1389450116666150806124345
Published on: 06 August, 2015

Advances in Inhibitors of FXa

Volume:16   Issue: 11
Pp: 1207-1232
Liwei Guo and Shutao Ma
DOI: 10.2174/1389450116666150518095533
Published on: 17 May, 2015

Cancer Kinases and its Novel Inhibitors: Past, Present and Future Challenges

Volume:16   Issue: 11
Pp: 1233-1245
Prathesha Pillai, R.S. Surenya, Shantikumar V. Nair and Vinoth-Kumar Lakshmanan
DOI: 10.2174/1389450116666150416120108
Published on: 16 April, 2015

Loop Diuretics Strategies in Acute Heart Failure: From Clinical Trials to Practical Application

Volume:16   Issue: 11
Pp: 1246-1253
Alberto Palazzuoli, Gaetano Ruocco, Marco Pellegrini, Matteo Beltrami, Gabriele Del Castillo and Ranuccio Nuti
DOI: 10.2174/1389450116666150420125531
Published on: 20 April, 2015

Bridging the Gap: The Potential Role of Corticosteroid Binding Globulin in Cardiac Steroid Facilitation

Volume:16   Issue: 11
Pp: 1254-1269
Hans Hendrik Schafer, Thomas Dieterle, Aaron Trachsler, Mikael Gencay and Edelgard Anna
DOI: 10.2174/1389450116666150408103806
Published on: 07 April, 2015